Palisade Asset Management LLC boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 40.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,490 shares of the conglomerate’s stock after buying an additional 5,000 shares during the period. Palisade Asset Management LLC’s holdings in Danaher Corporation were worth $1,500,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of DHR. GQG Partners LLC purchased a new position in Danaher Corporation in the second quarter valued at about $101,000. Proficio Capital Partners LLC grew its stake in Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares in the last quarter. Monetary Management Group Inc. grew its stake in Danaher Corporation by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after purchasing an additional 150 shares in the last quarter. Acrospire Investment Management LLC grew its stake in Danaher Corporation by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after purchasing an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC purchased a new position in Danaher Corporation in the first quarter valued at about $157,000. 75.38% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Corporation (DHR) opened at $93.33 on Tuesday. Danaher Corporation has a 12-month low of $76.27 and a 12-month high of $93.38. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The firm has a market capitalization of $64,162.62, a PE ratio of 23.71, a P/E/G ratio of 2.19 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The business had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the previous year, the firm earned $0.87 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. analysts forecast that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date was Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. Danaher Corporation’s dividend payout ratio is presently 16.52%.
In related news, insider William King sold 43,688 shares of the business’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the transaction, the insider now owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Donald J. Ehrlich sold 10,578 shares of the business’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total value of $960,693.96. Following the transaction, the director now directly owns 104,621 shares of the company’s stock, valued at approximately $9,501,679.22. The disclosure for this sale can be found here. Insiders have sold a total of 279,628 shares of company stock valued at $25,304,394 in the last three months. 12.20% of the stock is owned by insiders.
WARNING: “Danaher Corporation (DHR) Position Lifted by Palisade Asset Management LLC” was posted by Stock Observer and is the property of of Stock Observer. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.thestockobserver.com/2017/11/14/danaher-corporation-dhr-position-lifted-by-palisade-asset-management-llc.html.
A number of research analysts have commented on DHR shares. Jefferies Group LLC restated a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research note on Thursday, October 5th. Cowen and Company restated a “buy” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Wednesday, October 4th. Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.